Alfa Wassermann Diagnostic Technologies
Alfa Wassermann Diagnostic Technologies (AWDT), a New Jersey-based subsidiary of Alfa Wassermann, Inc., manufactures and distributes ACE Axcel and Vet Axcel clinical chemistry analyzers plus proprietary reagent panels to U.S. physician offices, small hospitals, veterinary practices, and biopharmaceutical research customers through authorized distributors.
- Company typePrivate
- Founded1960
- HeadquartersWest Caldwell, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Alfa Wassermann Diagnostic Technologies does
Alfa Wassermann Diagnostic Technologies (AWDT), a subsidiary of the privately held Alfa Wassermann, Inc., manufactures and distributes clinical chemistry analyzer systems and consumable reagents from its headquarters in West Caldwell, New Jersey. Founded approximately in the 1970s, the company operates in the United States with 11-50 employees and serves three primary customer segments: physician office laboratories and small hospitals, veterinary offices, and the biopharmaceutical research industry. Its flagship platforms are the ACE Axcel (physician and small-hospital use), Vet Axcel (veterinary applications), and a BioPharma Research variant, supplemented by reagent panels including a COVID-19 Reagent Panel introduced in May 2020.
The company earns revenue through three primary streams: one-time hardware sales of analyzer systems, recurring sales of proprietary reagents and consumables tied to the installed base, and paid extended service plans. Products are sold exclusively through authorized U.S. distributors — a channel model anchored by a 2015 distribution partnership with Medline — and supported by a nationwide network of company-trained engineers, 24/7 technical support, and PACE-accredited training programs. Go-to-market emphasis is on service reliability and channel enablement rather than direct enterprise sales, with Google AdWords remarketing and Google Analytics supporting modest digital demand generation.
AWDT differentiates on operational and reputational factors rather than technology novelty: over 50 years of manufacturing history and 21+ consecutive years of the NorthFace Scoreboard Award for Excellence in Customer Satisfaction (through 2023) form the core of its brand asset. As a privately held subsidiary with no disclosed funding rounds, M&A activity, or AI/ML initiatives, the business profile is that of a mature, service-led niche instrument and consumables vendor in the low- and mid-volume clinical chemistry segment.
Alfa Wassermann Diagnostic Technologies firmographics
Firmographics- Name
- Alfa Wassermann Diagnostic Technologies
- Legal name
- Alfa Wassermann Diagnostic Technologies, LLC
- Website
- https://alfawassermannus.com
- Company type
- Private
- Founded year
- 1960
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Alfa Wassermann Diagnostic Technologies (AWDT), a New Jersey-based subsidiary of Alfa Wassermann, Inc., manufactures and distributes ACE Axcel and Vet Axcel clinical chemistry analyzers plus proprietary reagent panels to U.S. physician offices, small hospitals, veterinary practices, and biopharmaceutical research customers through authorized distributors.
- Ownership category
- akta.pro rank
Alfa Wassermann Diagnostic Technologies industry classification
Industry- Product category
- Clinical Chemistry Diagnostic Instruments
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Surgical & Procedural Instruments (Scalpels, Forceps, Retractors) (HLAMAFAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
Keywords
Where Alfa Wassermann Diagnostic Technologies is headquartered
LocationHeadquarters
- HQ city
- West Caldwell
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Alfa Wassermann Diagnostic Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Chemistry Analyzers: Sale of clinical chemistry analyzer systems (ACE Axcel, Vet Axcel) to physician offices, hospitals, veterinary practices, and biopharmaceutical companies
- Reagents and Consumables: Sale of reagent panels and lab supplies for running the chemistry analyzers, including specialized panels like the COVID-19 Reagent Panel
- Service Plans: Extended service plans and technical support services available for purchase
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Alfa Wassermann Diagnostic Technologies product offering
Product offeringCore offering
Alfa Wassermann Diagnostic Technologies manufactures and supplies clinical chemistry analyzer systems (ACE Axcel for physician office laboratories, small hospitals, and biopharmaceutical research; Vet Axcel for veterinary practices) together with proprietary reagent panels used to run those analyzers. The company also offers extended service plans, on-site and PACE-accredited operator training, and 24/7 technical support delivered through a nationwide network of company-trained field engineers.
Differentiator
Problem solved
Functional benefit
Brands
- ACE Axcel: Clinical chemistry analyzer system for physician practices and small hospitals.
- Vet Axcel
- BioPharma Research
Products and services
- ACE Axcel Clinical Chemistry System Clinical chemistry analyzer system for physician office laboratories, small hospitals, and biopharmaceutical research applications, providing accurate in-office diagnostic testing for disease diagnosis, treatment, and monitoring.
- Vet Axcel Clinical Chemistry System Veterinary-specific clinical chemistry analyzer for animal health diagnostics, designed for veterinary practices that require reliable, species-appropriate chemistry testing.
- BioPharma Research Clinical Chemistry System Clinical chemistry analyzer configuration for biopharmaceutical research and development and quality control testing applications.
- COVID-19 Reagent Panel Reagent panel introduced for COVID-19 testing capability on Alfa Wassermann's ACE Axcel clinical chemistry analyzers, added to the reagent portfolio to address pandemic testing needs.
- Extended Service Plans Extended service plans and technical support services available for purchase to maintain Alfa Wassermann clinical chemistry analyzers, delivered via a nationwide network of company-trained engineers with 24/7 technical support coverage.
Quantifiable outcome
- 24/7 technical support availability
- +1 more outcomes
Companies that use Alfa Wassermann Diagnostic Technologies
Customer profileSegments3 records
Ideal customer profiles3 records
Alfa Wassermann Diagnostic Technologies technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Alfa Wassermann Diagnostic Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MedlineminorAlfa Wassermann Diagnostic Technologies became a new supplier to Medline in September 2015. AWDT supplies clinical chemistry analyzers and reagents through the Medline distribution channel.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Alfa Wassermann Diagnostic Technologies competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Offers the Atellica and ADVIA Centaur clinical chemistry and immunoassay systems. Comparable because Siemens serves similar hospital and reference lab customers with chemistry analyzers and reagent menus, even though its portfolio extends well beyond AWDT's specialty focus.
- Beckman Coulter Diagnostics: Manufactures the AU clinical chemistry analyzer series used in mid- to high-volume hospital labs. Comparable because it competes in the same clinical chemistry reagent/instrument category serving hospitals, though at a different throughput tier than AWDT.
- Roche Diagnostics: Global IVD leader offering the cobas clinical chemistry and integrated chemistry/immunoassay platforms. Comparable because Roche competes in the same clinical chemistry analyzer category across hospitals and physician office labs, though it operates at vastly greater scale and breadth than AWDT.
- Abbott Diagnostics: Provides the Architect and Alinity clinical chemistry analyzer families used in hospitals and mid-volume labs. Comparable as a direct competitor in clinical chemistry instrumentation, though Abbott also offers immunoassay and point-of-care platforms that go beyond AWDT's scope.
Direct peers
- ELITechGroup: Supplies clinical chemistry analyzers (Selectra, Flexor) and reagents for small-to-mid volume laboratories. Comparable as a smaller, specialty clinical chemistry vendor with overlapping physician office and small hospital customer profile.
- Ortho Clinical Diagnostics: Provides the VITROS clinical chemistry and immunoassay systems for hospital and reference labs. Comparable as a focused clinical chemistry instrumentation competitor serving similar hospital and mid-volume lab customers with reagent-driven recurring revenue.
- IDEXX Laboratories: Dominant veterinary diagnostics provider with the Catalyst and VetLab chemistry/hematology platforms. Comparable because IDEXX directly competes with AWDT's Vet Axcel in the veterinary clinical chemistry analyzer category.
- HORIBA Medical: Manufactures the Pentra and Yumizen clinical chemistry analyzer lines for small to mid-volume labs. Comparable because HORIBA directly competes in the lower-throughput clinical chemistry space that AWDT's ACE Axcel targets, including physician office and small hospital settings.
- Randox Laboratories: Offers the RX series clinical chemistry analyzers for physician office, veterinary, and research settings. Comparable because Randox directly overlaps with AWDT across the physician office lab, veterinary, and biopharma research segments.
Emerging players
- Mindray Bio-Medical: Provides the BS series clinical chemistry analyzers and integrated lab solutions for hospitals and mid-volume labs. Comparable because Mindray competes in the same chemistry analyzer category with growing US presence, though at broader scale and price tiers than AWDT.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Alfa Wassermann Diagnostic Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Alfa Wassermann Diagnostic Technologies leadership team
Management profileNumber of profiles
Profiles1 record
Alfa Wassermann Diagnostic Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Alfa Wassermann Diagnostic Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Alfa Wassermann Diagnostic Technologies
What does Alfa Wassermann Diagnostic Technologies do?
Alfa Wassermann Diagnostic Technologies manufactures and supplies clinical chemistry analyzer systems (ACE Axcel for physician office laboratories, small hospitals, and biopharmaceutical research; Vet Axcel for veterinary practices) together with proprietary reagent panels used to run those analyzers. The company also offers extended service plans, on-site and PACE-accredited operator training, and 24/7 technical support delivered through a nationwide network of company-trained field engineers.
Is Alfa Wassermann Diagnostic Technologies a public or private company?
Alfa Wassermann Diagnostic Technologies is a private company. It is classified as corporate owned and is currently operating.
When was Alfa Wassermann Diagnostic Technologies founded?
Alfa Wassermann Diagnostic Technologies was founded in 1960. It employs 11 to 50 people.
Where is Alfa Wassermann Diagnostic Technologies based?
Alfa Wassermann Diagnostic Technologies is headquartered in West Caldwell, United States, in the North America region.
How does Alfa Wassermann Diagnostic Technologies make money?
Three revenue lines are on record. Clinical Chemistry Analyzers are the primary driver. The others are reagents and Consumables and service Plans.
Who are Alfa Wassermann Diagnostic Technologies's main competitors?
Broad incumbents on record are Siemens Healthineers, Beckman Coulter Diagnostics, Roche Diagnostics and Abbott Diagnostics. Direct peers are ELITechGroup, Ortho Clinical Diagnostics, IDEXX Laboratories, HORIBA Medical and Randox Laboratories. Mindray Bio-Medical is listed as an emerging player.
Does Alfa Wassermann Diagnostic Technologies have an API?
No public API is recorded for Alfa Wassermann Diagnostic Technologies.
What industry is Alfa Wassermann Diagnostic Technologies in?
Alfa Wassermann Diagnostic Technologies's product category is Clinical Chemistry Diagnostic Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAMAFAA, Surgical & Procedural Instruments (Scalpels, Forceps, Retractors). Its NAICS code is 334510 and its SIC code is 3841.